ipragliflozin

Ligand id: 9394

Name: ipragliflozin

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 4
Rotatable bonds 4
Topological polar surface area 118.39
Molecular weight 404.11
XLogP 3.57
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Ipragliflozin is approved for use in Japan, the Republic of Korea and Thailand, for the treatment of type 2 diabetes. Phase 3 clinical trial results are reported in [3].